Myeg returned for augmented reality technology developer HiScene's $41.6m series C-plus round while celiac disease drug developer Calypso Biotech hiked a corporate-backed round to over $33m.

The Progressive-backed neobank has secured the fresh funding at a reported $2.5bn valuation, seven months after it closed a $63m round.

Allianz has recommitted to the venture capital firm having funded its $170m debut vehicle two years ago.

Reckitt Benckiser, Emerson Group, McKesson and Sealed Air are set to score exits from the e-commerce services provider.

Disease diagnostics technology developer Mammoth Biosciences is valued at over $1bn following funding rounds backed by investors including Amazon.

Sanofi and Alexandria Real Estate Equities could exit the chronic disease therapeutics developer, which has set the range for an offering that could raise up to $170m.

First Data will exit MineralTree after Global Payments agreed to purchase the payment automation technology producer.

First American participated in a round that tipped the real estate platform developer's valuation over the $1bn mark.

Illumina’s corporate venturing unit took part in a round that brought the proteomic platform developer’s overall funding to $110m.

Ericsson Ventures has participated in a series B round for cybersecurity software provider TrueFort, reportedly increasing its total funding to almost $48m.